Clinical trial
Phase-2 Trial of Parcel-guided rTMS for Major Depressive Disorder
NCT07287839 is registered in ClinicalTrials.gov with Soterix Medical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase-2 Trial of Parcel-guided rTMS for Major Depressive Disorder
- Lead sponsor
- Soterix Medical
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- December 15, 2025
- Completion date
- June 15, 2028
- Enrollment
- 60 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
treatment resistant depression (trd)